Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis

Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis

The Korean government decided to schedule heterologous vaccinations on dialysis patients for early achievement of immunization against Coronavirus disease 2019(COVID-19). However, the effects of heterologous immunizations in hemodialysis (HD) patients are unclear. One hundred (HD) patients from Gang...

Full description

Bibliographic Details
Main Authors: Dae Kyu Kim, Su Woong Jung, Ju-Young Moon, Kyung Hwan Jeong, Hyeon Seok Hwang, Jin Sug Kim, Sang-Ho Lee, So-Young Kang, Yang Gyun Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
ChAdOx1
BNT162b2
hemodialysis
anti-RBD IgG
heterologous vaccination
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.894700/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.894700/full

Similar Items